Cartesian Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $147.6M | $118.6M | $125.1M | $143.4M | $160.3M | $180.4M | $212.6M | $219.2M |
| Accounts Receivable | $196.0K | $261.0K | $1.1M | $722.0K | $354.0K | $1.8M | $872.0K | $4.8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $153.6M | $122.0M | $129.3M | $147.3M | $163.4M | $185.1M | $216.6M | $229.1M |
| Property, Plant & Equipment | $11.3M | $11.6M | $12.2M | $12.4M | $12.3M | $10.2M | $9.9M | $10.2M |
| Goodwill | $48.2M | $48.2M | $48.2M | $48.2M | $48.2M | $48.2M | $48.2M | $48.2M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $318.6M | $288.4M | $296.4M | $372.7M | $388.9M | $409.1M | $435.0M | $455.3M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $1.6M | $1.3M | $2.2M | $454.0K | $2.1M | $288.0K | $517.0K |
| Total Current Liabilities | $20.6M | $15.9M | $14.9M | $13.8M | $12.3M | $15.0M | $23.0M | $21.4M |
| Long-Term Debt | $52.9M | — | $0 | — | — | — | — | — |
| Total Liabilities | $443.9M | $436.5M | $422.7M | $408.5M | $391.4M | $430.9M | $441.8M | $454.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-845.8M | $-861.6M | $-822.4M | $-729.8M | $-693.9M | $-709.8M | $-692.1M | $-681.8M |
| Total Stockholders' Equity | $-125.2M | $-148.1M | $-126.2M | $-35.8M | $-2.5M | $-21.8M | $-6.8M | $752.0K |